Flamsa Sequential Chemotherapy Followed By Reduced Intensity Conditioning and Allogeneic Hematopoietic Transplantation for High Risk Acute Myeloid Leukemia Patients
Mauricette Michallet(Université Claude Bernard Lyon 1), Xavier Thomas(Hôpital Lyon Sud), Marie Y. Detrait(Hôpital Civil de Charleroi), Mohamed Elhamri(Hôpital Edouard Herriot), Fiorenza Barraco(Hôpital Lyon Sud), Laure Lebras(Centre Léon Bérard), Isabelle Tigaud(Inserm), Franck E. Nicolini(Université Claude Bernard Lyon 1), Hélène Labussière‐Wallet(Hospices Civils de Lyon), Valentina Bozzoli(Università Cattolica del Sacro Cuore), Mohamad Sobh(Ottawa Hospital), Sophie Ducastelle(Hôpital Lyon Sud), Sandrine Hayette(Hôpital Claude Huriez), Lila Gilis(Hospices Civils de Lyon)
Cited by 2
Related Papers
Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study
|The Lancet|2012|1k
Should Adolescents With Acute Lymphoblastic Leukemia Be Treated as Old Children or Young Adults? Comparison of the French FRALLE-93 and LALA-94 Trials
|Journal of Clinical Oncology|2003|606
Pediatric-Inspired Therapy in Adults With Philadelphia Chromosome–Negative Acute Lymphoblastic Leukemia: The GRAALL-2003 Study
|Journal of Clinical Oncology|2009|562
Outcome of Treatment in Adults With Acute Lymphoblastic Leukemia: Analysis of the LALA-94 Trial
|Journal of Clinical Oncology|2004|547